Page last updated: 2024-08-23

haloperidol decanoate and paliperidone palmitate

haloperidol decanoate has been researched along with paliperidone palmitate in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bø, CN; Einarson, TR; Hemels, ME; Jensen, R; Piwko, C; Pudas, H; Vicente, C; Zilbershtein, R1
Goff, DC1
Buckley, PF; Byerly, M; Dominik, R; Hamer, RM; Lamberti, JS; McEvoy, JP; Ray, N; Rosenheck, RA; Stroup, TS; Swartz, MS; Wilkins, TM1
Byerly, MJ; Hamer, RM; Leslie, DL; Li, Y; Lin, H; McEvoy, JP; Rosenheck, RA; Sint, KJ; Stroup, TS; Swartz, MS1
Ide, GD; Khan, AY; Ovais, M; Salaria, S1
De Vos, C; Decuypere, F; Denee, TR; Geerts, P; Lamotte, M; Malfait, B; Mulder, CL; Sermon, J1
Tagne Nouemssi, AB1
Bareis, NA; McEvoy, JP; Rosenheck, RA; Stroup, TS; Swartz, MS1
Ansolabehere, X; Guillon, P; Harmand, S1

Reviews

1 review(s) available for haloperidol decanoate and paliperidone palmitate

ArticleYear
Depot antipsychotics: Where do we stand?
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2016, Volume: 28, Issue:4

    Topics: Antipsychotic Agents; Haloperidol; Hospitalization; Humans; Medication Adherence; Paliperidone Palmitate; Schizophrenia

2016

Trials

3 trial(s) available for haloperidol decanoate and paliperidone palmitate

ArticleYear
Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial.
    JAMA, 2014, May-21, Volume: 311, Issue:19

    Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Double-Blind Method; Female; Haloperidol; Hospitalization; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Palmitates; Schizophrenia; Treatment Failure; Treatment Outcome; Weight Gain

2014
Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia.
    Psychiatric services (Washington, D.C.), 2016, 10-01, Volume: 67, Issue:10

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cost-Benefit Analysis; Delayed-Action Preparations; Double-Blind Method; Female; Haloperidol; Humans; Injections; Male; Middle Aged; Outcome Assessment, Health Care; Paliperidone Palmitate; Patient Acceptance of Health Care; Psychotic Disorders; Quality-Adjusted Life Years; Schizophrenia; United States; Young Adult

2016
Heterogeneity of Treatment Effects of Long-Acting Injectable Antipsychotic Medications.
    The Journal of clinical psychiatry, 2018, 11-27, Volume: 80, Issue:1

    Topics: Adolescent; Adult; Affective Disorders, Psychotic; Age Factors; Aged; Antipsychotic Agents; Delayed-Action Preparations; Female; Haloperidol; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Paliperidone Palmitate; Progression-Free Survival; Schizophrenia; Treatment Failure; Young Adult

2018

Other Studies

5 other study(ies) available for haloperidol decanoate and paliperidone palmitate

ArticleYear
Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden.
    Nordic journal of psychiatry, 2014, Volume: 68, Issue:6

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost of Illness; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Costs; Female; Haloperidol; Health Care Costs; Hospitalization; Humans; Isoxazoles; Male; Middle Aged; Models, Econometric; Olanzapine; Paliperidone Palmitate; Palmitates; Quality-Adjusted Life Years; Risperidone; Schizophrenia; Sweden

2014
Maintenance treatment with long-acting injectable antipsychotics: comparing old with new.
    JAMA, 2014, May-21, Volume: 311, Issue:19

    Topics: Antipsychotic Agents; Female; Haloperidol; Humans; Isoxazoles; Male; Paliperidone Palmitate; Palmitates

2014
Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database study.
    PloS one, 2017, Volume: 12, Issue:6

    Topics: Adult; Antipsychotic Agents; Belgium; Benzodiazepines; Delayed-Action Preparations; Drug Administration Schedule; Female; Haloperidol; Humans; Medication Adherence; Netherlands; Olanzapine; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome

2017
Risperidone-associated sinus tachycardia potentiated by paliperidone palmitate in a patient with no prior cardiovascular disease: role of risperidone-related autonomic instability.
    BMJ case reports, 2018, Apr-21, Volume: 2018

    Topics: Antipsychotic Agents; Autonomic Nervous System; Cardiovascular Diseases; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combination; Haloperidol; Humans; Male; Paliperidone Palmitate; Risperidone; Schizophrenia; Tachycardia, Sinus; Treatment Outcome; Young Adult

2018
Real-life persistence of long-acting injectable antipsychotics in schizophrenic patients: A retrospective observational study in France
.
    International journal of clinical pharmacology and therapeutics, 2019, Volume: 57, Issue:9

    Topics: Antipsychotic Agents; Delayed-Action Preparations; France; Haloperidol; Humans; Injections; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia

2019